SCHEMBL5701310

SCHEMBL5701310

C1=CCC(OC2C=CC=CC2)C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12677149 0.79
SCHEMBL30981586 0.78
SCHEMBL19383182 0.78
SCHEMBL11003979 0.78
SCHEMBL7770031 0.78
SCHEMBL16922203 0.78
SCHEMBL21183016 0.76 HRH1 (0.32)
SCHEMBL27992586 0.74
SCHEMBL22954150 0.72
SCHEMBL13075138 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5429936-A Haptens, Claisen rearrangement THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-07-04 US claimed
JP-2029454-A None JP disclosed
US-20110237636-A1 Hepatitis C Virus Inhibitors BRISTOL-MYERS SQUIBB COMPANY 2011-09-29 US disclosed
EP-1280500-B1 SYNERGISTIC ANTIPLAQUE/ANTIGINGIVITIS ORAL COMPOSITION COLGATE PALMOLIVE CO (US) 2006-06-28 EP disclosed
EP-1280500-A2 SYNERGISTIC ANTIPLAQUE/ANTIGINGIVITIS ORAL COMPOSITION Colgate-Palmolive Company (US) 2003-02-05 EP disclosed
WO-2001085116-A2 SYNERGISTIC ANTIPLAQUE/ANTIGINGIVITIS ORAL COMPOSITION COLGATE-PALMOLIVE COMPANY (US) 2001-11-15 WO disclosed
US-5429936-A Haptens, Claisen rearrangement THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-07-04 US disclosed
US-5100879-A Disinfection for retroviruses by cleansing with dextran sulfate K.K. UENO SEIYAKU OYO KENKYUJO (JP) 1992-03-31 US disclosed
JP-H0229454-A THERMOPLASTIC MOLDING MATERIAL AND ITS MANUFACTURE HUELS AG 1990-01-31 JP disclosed